Vaccines - Lesotho | Statista Market Forecast

The Vaccines market in Lesotho is projected to reach a revenue of US$4.17m in 2024.
It is expected to show an annual growth rate (CAGR 2024-2029) of -7.36%, resulting in a market volume of US$2.84m by 2029.
In global comparison, United States is anticipated to generate the most revenue, with US$29.12bn in 2024.
Lesotho's vaccine market is experiencing a surge in demand due to the government's efforts to improve healthcare accessibility.

Definition:
This market covers vaccines against infectious diseases. They help to prevent diseases, usually through active immunization. Vaccines against infectious diseases transmitted by viruses (e.g., hepatitis A and B or COVID-19) and bacteria (e.g., typhoid fever or meningococcus) are included.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Pfizer, GlaxoSmithKline, Merck & Co, Sanofi, Moderna, AstraZeneca

Vaccines against infectious diseases
Prophylactic and therapeutic vaccines
Flu vaccines
COVID-19 vaccines

Sera and gammaglobulins
Antivirals
Antibiotics

Lesotho, a small landlocked country in Southern Africa, has been making strides in the healthcare sector in recent years. The Vaccines market in Lesotho has seen a significant development due to various factors.

Customer preferences: Lesotho has a high demand for vaccines due to its high burden of infectious diseases, such as HIV, tuberculosis, and malaria. The government of Lesotho has been focusing on expanding access to vaccines for its citizens, especially children, through various immunization programs.

Trends in the market: The vaccines market in Lesotho has been growing steadily due to the increasing demand for vaccines. The government has been investing in the procurement of vaccines and expanding the immunization program to reach more people. Additionally, there has been an increase in private sector participation in the vaccines market, which has led to the availability of a wider range of vaccines.

Local special circumstances: Lesotho faces several challenges in the healthcare sector, including a shortage of healthcare workers, inadequate healthcare infrastructure, and a high burden of infectious diseases. The government has been working to address these challenges through various initiatives, such as increasing the number of healthcare workers, improving healthcare infrastructure, and expanding access to vaccines.

Underlying macroeconomic factors: Lesotho's economy is heavily dependent on agriculture, but the government has been working to diversify the economy through various initiatives. The healthcare sector has been identified as a priority sector for development, and the government has been investing in the sector to improve access to healthcare services, including vaccines. Additionally, Lesotho has been receiving support from international organizations, such as the World Health Organization and UNICEF, to improve its healthcare system.In conclusion, the vaccines market in Lesotho has been developing due to the increasing demand for vaccines and the government's efforts to expand access to vaccines. The challenges faced by the healthcare sector in Lesotho have been addressed through various initiatives, and the government has been investing in the sector to improve access to healthcare services.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

As of March 2023, more than 13 billion COVID-19 vaccine doses had been administered worldwide. Wide-spread vaccine availability, increasing herd immunity, and lower case numbers led to renewed hope and a feeling of normality in 2023. However, especially during the winter seasons and with the potential emergence of new variants of the virus (like Omicron in 2021-2022), tracking of coronavirus cases repeatedly becomes a focus for the public. Thus, there is a level of uncertainty about what developments the winter season 2023/2024 might bring.